It's always fun to share great business performance news so I'm delighted to report key financial results and briefly opine on our prospects for 2012. Our new deal bookings grew by 35% over FY10 and total bookings grew by 23%. Further, we are going into the new year with solid momentum. Second-half 2011 revenue was 34% greater than in the first half and an exceptionally strong fourth quarter capped a year of accelerating market momentum. As a result, our pipeline has never been stronger.Growth continues to be driven by a strong balance of new account acquisitions and revenue contributions from existing accounts moving forward with significant footprint expansions. New accounts and/or expanding deployments in the second-half included Comerica, Blue Cross Blue Shield of Nebraska, NCR, WEA Trust, Unipart, PHH Mortgage, Optus, Genco ATC, College of American Pathologist, Johnson & Johnson, Western Australia Department of Health, Roche and Grace. I attribute the strong market and account penetration to our focus on high customer satisfaction and user acceptance levels, continuous usability improvements to our flagship solution for EPPM (EnterpriseTrack™) and our Enterprise PPM strategy.We are seeing validation of our Enterprise PPM strategy of taking a more integrated and top-down approach to managing all project-intensive work and resources across the enterprise leveraging a single system. By far the largest growth segment of our business is organizations that are looking to use EnterpriseTrack to manage simultaneously more than one project portfolio type, such as IT PPM and PMO, new product development and innovation, and process excellence. And, now many of customers are starting to see the benefits like improved strategy and program execution, enterprise-wide resource management, and enhanced project-portfolio-related decision support through executive-level dashboards and reports.We are excited about the market momentum we have generated from customer successes, analyst endorsements and awards (see below for latest), partner leverage and planned product innovations. And, we are investing in all aspects of the business to support the record business growth we are forecasting in 2012.It's always fun to share great business performance news so I'm delighted to report key financial results and briefly opine on our prospects for 2012. Our new deal bookings grew by 35% over FY10 and total bookings grew by 23%. Further, we are going into the new year with solid momentum. Second-half 2011 revenue was 34% greater than in the first half and an exceptionally strong fourth quarter capped a year of accelerating market momentum. As a result, our pipeline has never been stronger.
 
Growth continues to be driven by a strong balance of new account acquisitions and revenue contributions from existing accounts moving forward with significant footprint expansions. New accounts and/or expanding deployments in the second-half included Comerica, Blue Cross Blue Shield of Nebraska, NCR, WEA Trust, Unipart, PHH Mortgage, Optus, Genco ATC, College of American Pathologist, Johnson & Johnson, Western Australia Department of Health, Roche and Grace. I attribute the strong market and account penetration to our focus on high customer satisfaction and user acceptance levels, continuous usability improvements to our flagship solution for EPPM (EnterpriseTrack™) and our Enterprise PPM strategy.


We are seeing validation of our Enterprise PPM strategy of taking a more integrated and top-down approach to managing all project-intensive work and resources across the enterprise leveraging a single system. By far the largest growth segment of our business is organizations that are looking to use EnterpriseTrack to manage simultaneously more than one project portfolio type, such as IT PPM and PMO, new product development and innovation, and process excellence. And, now many of customers are starting to see the benefits like improved strategy and program execution, enterprise-wide resource management, and enhanced project-portfolio-related decision support through executive-level dashboards and reports.


We are excited about the market momentum we have generated from customer successes, analyst endorsements and awards (see below for latest), partner leverage and planned product innovations. And, we are investing in all aspects of the business to support the record business growth we are forecasting in 2012. 
  It's always fun to share great business performance news so I'm delighted to report key financial results and briefly opine on our prospects for 2012. In FY11 our new deal bookings grew by 39% over FY10 and total bookings grew by 26%. Further, we are going into the new year with solid momentum. Second-half 2011 revenue was 38% greater than in the first half and an exceptionally strong fourth quarter capped a year of accelerating market momentum. As a result, our pipeline has never been stronger.

Growth continues to be driven by a balance of new account acquisitions and footprint expansions at existing accounts representing diverse industries and geographies. Most recently these include College of American Pathologists, Comerica Bank, Genco, Johnson & Johnson, Momentive Specialty Chemicals, NCR, Optus, Roche, Unipart, WEA Trust, Western Australia Department of Health and W.R. Grace & Co.

I attribute the strong market and account penetration to our focus on high customer satisfaction and user acceptance levels, continuous usability improvements to our flagship solution for EPPM (EnterpriseTrack™) and our Enterprise PPM strategy. We are seeing quite a bit of validation of our Enterprise PPM strategy of taking a more integrated and top-down approach to managing all project-intensive work and resources across the enterprise leveraging a single system. By far the largest growth segment of our business is organizations that are looking to use EnterpriseTrack to manage simultaneously more than one project portfolio type, such as IT PPM and PMO, new product development and innovation, and process excellence.

We are excited about the market momentum we have generated from customer successes, analyst endorsements and awards (see below for latest), partner leverage and planned product innovations. And, we are investing in all aspects of the business to support the record business growth we are forecasting for 2012.